Smart + Strong.
All Rights Reserved.
Smart + Strong®
is a registered trademark of CDM Publishing, LLC.
EBV causes chromosome breakage that can trigger a cascade of genomic instability leading to tumor growth.
A Damon Runyon scientist investigates the role of aneuploidy, or abnormal chromosome number, in cancer—and in possible treatments.
The 2024 Timmerman Traverse aims to raise at least $1 million for Damon Runyon’s cancer research. [VIDEO]
Balachandran’s work could “transform the treatment of pancreatic cancer…and provide proof of concept for future cancer vaccines.”
Runners and walkers ranging in age from 5 to 87 traversed the course at Yankee Stadium alongside scientists funded by Damon Runyon.
Researchers unveil a less toxic, more efficient method to genetically engineer immune cells that target tumor cells.
Because of its rarity, adenoid cystic carcinoma has received relatively little attention from cancer researchers.
These individuals work to ensure fair opportunities to prevent, treat and survive cancer.
And learn about the cutting-edge work of these early-career physician-scientists named the 2023 Damon Runyon Clinical Investigators.
These datasets may measure a patient’s response to a new COVID-19 variant or to cancer-causing viruses like human papillomavirus (HPV).
The Damon Runyon Cancer Research Foundation will increase its fellowship stipend.
New results from the AEGEAN clinical trial offer good news to people with non-small cell lung cancer.
Vallurupalli, of Dana-Farber Cancer Institute, researches blood cancers and is passionate about equitable access to precision cancer care.
The awardees were selected through a highly competitive and rigorous process by a scientific committee.
Seaweed-based nanoparticles may offer a way to deliver cancer drugs directly to brain tumors.
If you carry genetic risk factors for cancer, is there anything preventative you can do?
You have been inactive for 60 minutes and will be logged out in . Any updates not saved will be lost.
Click here to log back in.